Fresenius Medical Care

Fresenius Medical Care's total reported carbon emissions for 2025 were approximately 3.87 billion kg CO2e. This included Scope 1 emissions of approximately 365.2 million kg CO2e, Scope 2 market-based emissions of about 284.4 million kg CO2e, and Scope 3 emissions of approximately 3.09 billion kg CO2e.

Looking back, their total emissions were approximately 3.73 billion kg CO2e in 2024, and about 3.47 billion kg CO2e in 2023.

Fresenius Medical Care, headquartered in the US, has established ambitious climate commitments. The company has set near-term Science Based Targets initiative (SBTi) validated targets to reduce absolute Scope 1 and 2 GHG emissions by 50% by 2030, from a 2020 base year. Additionally, they aim to reduce absolute Scope 3 GHG emissions from fuel- and energy-related activities, business travel, and use of sold products by 25% by 2030, from a 2024 base year.

For the long term, Fresenius Medical Care AG commits to achieving net-zero greenhouse gas emissions across its entire value chain by 2050. This includes reducing absolute Scope 1 and 2 GHG emissions by 90% by 2050 from a 2020 base year, and absolute Scope 3 GHG emissions by 90% by 2050 from a 2024 base year. These targets are consistent with keeping warming to 1.5°C, aligning with the Paris Agreement goals. The company also aims for 70% of its suppliers by emissions covering purchased goods and services, capital goods, and upstream transportation and distribution, to have science-based targets by 2030.